PARK SURGERY
ALBION WAY, HORSHAMCKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 291 | 347 | 83.9% | |
CKD 4 | 2008 | 471 | 612 | 77.0% | |
CKD 5 | 2009 | 78 | 93 | 83.9% | |
CKD 5 | 2010 | 28 | 33 | 84.8% | |
CKD 5 | 2011 | 22 | 28 | 78.6% | |
CKD 5 | 2012 | 25 | 28 | 89.3% | |
CKD 5 | 2013 | 90 | 110 | 81.8% | |
CKD003 | 2014 | 98 | 116 | 84.5% | |
CKD003 | 2015 | 85 | 98 | 86.7% | |
NM84 | 2016 | 79 | 118 | 66.9% | |
NM84 | 2017 | 68 | 104 | 65.4% | |
NM84 | 2018 | 60 | 99 | 60.6% | |
NM84 | 2019 | 29 | 43 | 67.4% | |
NM84 | 2020 | 29 | 42 | 69.0% | |
NM84 | 2022 | 21 | 37 | 56.8% | |
NM84 | 2023 | 27 | 43 | 62.8% |